![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Apeiron Capital Investment Corp | NYSE:APN | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.37 | 0 | 01:00:00 |
| , 2022 | | | By Order of the Board of Directors | |
| | | |
Joel Shulman
Chairman and Chief Executive Officer |
|
| , 2022 | | | By Order of the Board of Directors | |
| | | |
Joel Shulman
Chairman and Chief Executive Officer |
|
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 12 | | | |
| | | | 13 | | | |
| | | | 16 | | | |
| | | | 17 | | | |
| | | | 20 | | | |
| | | | 26 | | | |
| | | | 27 | | | |
| | | | 28 | | | |
| | | | 32 | | | |
| | | | 40 | | | |
| | | | 42 | | | |
| | | | 44 | | | |
| | | | 44 | | | |
| | | | 44 | | | |
| | | | A-1 | | |
Name
|
| |
Age
|
| |
Position
|
|
Dr. Joel Shulman | | |
55
|
| | Chairman and Chief Executive Officer | |
Eva Adosoglou | | |
31
|
| | Chief Operating Officer | |
Grant Grigorian | | |
59
|
| | Chief Financial Officer | |
Kevin Cramton | | |
61
|
| | Director | |
Charles Aggouras | | |
55
|
| | Director | |
Jeffrey Mortimer | | |
57
|
| | Director | |
| | |
Class A Common Stock
|
| |
Class B Common Stock
|
| |
Approximate
Percentage of Outstanding Common Stock |
| |||||||||||||||||||||
Name and Address of Beneficial Owner(1)
|
| |
Number of
Shares Beneficially Owned |
| |
Approximate
Percentage of Class |
| |
Number of
Shares Beneficially Owned |
| |
Approximate
Percentage of Class |
| ||||||||||||||||||
Apeiron Capital Sponsor, LLC(2)
|
| | | | — | | | | | | — | | | | | | 4,312,500 | | | | | | 100% | | | | | | 20% | | |
Joel Shulman(3)
|
| | | | — | | | | | | — | | | | | | 4,312,500 | | | | | | 100% | | | | | | 20% | | |
Eva Adosoglou(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Grant Grigorian(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Kevin Cramton(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Charles Aggouras(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Jeffrey Mortimer(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
All executive officers and directors as a group
(six individuals) |
| | | | — | | | | | | — | | | | | | 4,312,500 | | | | | | 100% | | | | | | 20% | | |
Other 5% Stockholders | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Highbridge Capital Management, LLC(4)
|
| | | | 1,179,474 | | | | | | 6.84% | | | | | | — | | | | | | — | | | | | | 5.5% | | |
Calamos Market Neutral Income Fund(5)
|
| | | | 1,000,000 | | | | | | 5.8% | | | | | | — | | | | | | — | | | | | | 4.6% | | |
Saba Capital Management L.P.(6)
|
| | | | 1,300,000 | | | | | | 7.5% | | | | | | — | | | | | | — | | | | | | 6.0% | | |
| | | | APEIRON CAPITAL INVESTMENT CORP. | |
| | | |
By:
|
|
| | | | Name: Dr. Joel Shulman | |
| | | | Title: Chief Executive Officer | |
1 Year Apeiron Capital Investment Chart |
1 Month Apeiron Capital Investment Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions